Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting

<p>Abstract</p> <p>Background</p> <p>To assess differences in outpatient costs among pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting.</p> <p>Methods</p> <p>A retrospective case...

Full description

Bibliographic Details
Main Authors: Bosmans Judith E, Adriaanse Marcel C
Format: Article
Language:English
Published: BMC 2012-02-01
Series:BMC Health Services Research
Online Access:http://www.biomedcentral.com/1472-6963/12/46
_version_ 1818443837572382720
author Bosmans Judith E
Adriaanse Marcel C
author_facet Bosmans Judith E
Adriaanse Marcel C
author_sort Bosmans Judith E
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>To assess differences in outpatient costs among pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting.</p> <p>Methods</p> <p>A retrospective case control study over 3 years (2002-2004). Data on 7128 depressed patients and 23772 non-depressed matched controls were available from the electronic medical record system of 20 general practices organized in one large primary care organization in the Netherlands. A total of 393 depressed patients with diabetes and 494 non-depressed patients with diabetes were identified in these records. The data that were extracted from the medical record system concerned only outpatient costs, which included GP care, referrals, and medication.</p> <p>Results</p> <p>Mean total outpatient costs per year in depressed diabetes patients were €1039 (SD 743) in the period 2002-2004, which was more than two times as high as in non-depressed diabetes patients (€492, SD 434). After correction for age, sex, type of insurance, diabetes treatment, and comorbidity, the difference in total annual costs between depressed and non-depressed diabetes patients changed from €408 (uncorrected) to €463 (corrected) in multilevel analyses. Correction for comorbidity had the largest impact on the difference in costs between both groups.</p> <p>Conclusions</p> <p>Outpatient costs in depressed patients with diabetes are substantially higher than in non-depressed patients with diabetes even after adjusting for confounders. Future research should investigate whether effective treatment of depression among diabetes patients can reduce health care costs in the long term.</p>
first_indexed 2024-12-14T19:06:23Z
format Article
id doaj.art-404b48d1a75740d697d0db179da36179
institution Directory Open Access Journal
issn 1472-6963
language English
last_indexed 2024-12-14T19:06:23Z
publishDate 2012-02-01
publisher BMC
record_format Article
series BMC Health Services Research
spelling doaj.art-404b48d1a75740d697d0db179da361792022-12-21T22:50:50ZengBMCBMC Health Services Research1472-69632012-02-011214610.1186/1472-6963-12-46Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care settingBosmans Judith EAdriaanse Marcel C<p>Abstract</p> <p>Background</p> <p>To assess differences in outpatient costs among pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting.</p> <p>Methods</p> <p>A retrospective case control study over 3 years (2002-2004). Data on 7128 depressed patients and 23772 non-depressed matched controls were available from the electronic medical record system of 20 general practices organized in one large primary care organization in the Netherlands. A total of 393 depressed patients with diabetes and 494 non-depressed patients with diabetes were identified in these records. The data that were extracted from the medical record system concerned only outpatient costs, which included GP care, referrals, and medication.</p> <p>Results</p> <p>Mean total outpatient costs per year in depressed diabetes patients were €1039 (SD 743) in the period 2002-2004, which was more than two times as high as in non-depressed diabetes patients (€492, SD 434). After correction for age, sex, type of insurance, diabetes treatment, and comorbidity, the difference in total annual costs between depressed and non-depressed diabetes patients changed from €408 (uncorrected) to €463 (corrected) in multilevel analyses. Correction for comorbidity had the largest impact on the difference in costs between both groups.</p> <p>Conclusions</p> <p>Outpatient costs in depressed patients with diabetes are substantially higher than in non-depressed patients with diabetes even after adjusting for confounders. Future research should investigate whether effective treatment of depression among diabetes patients can reduce health care costs in the long term.</p>http://www.biomedcentral.com/1472-6963/12/46
spellingShingle Bosmans Judith E
Adriaanse Marcel C
Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
BMC Health Services Research
title Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
title_full Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
title_fullStr Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
title_full_unstemmed Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
title_short Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
title_sort outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a dutch primary care setting
url http://www.biomedcentral.com/1472-6963/12/46
work_keys_str_mv AT bosmansjudithe outpatientcostsinpharmaceuticallytreateddiabetespatientswithandwithoutadiagnosisofdepressioninadutchprimarycaresetting
AT adriaansemarcelc outpatientcostsinpharmaceuticallytreateddiabetespatientswithandwithoutadiagnosisofdepressioninadutchprimarycaresetting